Biogen Inc. (BIIB) Stock Overview
Explore Biogen Inc.’s financial performance, market position, analyst ratings, and future outlook.
Biogen Inc. (BIIB)
Key Financials
Key Financials
Market Cap
29.4B
P/E Ratio
21.17
EPS (TTM)
$9.30
ROE
0.08%
BIIB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Biogen Inc. (BIIB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $115.21.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.17 and a market capitalization of 29.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.